Tuesday, December 20, 2016
Indians Add Chris Colabello
The Indians have signed a first baseman from the Toronto Blue Jays but he's probably not the one fans wanted. During the winter meetings the name on many fan's lips was Edwin Encarnacion but the Tribe have opted for his teammate Chris Colabello, signing him to a minor league deal today.
Colabello is a 33 year-old right handed first baseman who will add some depth to the position, rather than solve the problem outright. In 2015 Colabello had a very impressive start to his career in Toronto, slashing .321/.367.520 (BA/OBP/SLG) over 101 games, with 15 home runs. It was good enough for a 138 OPS+ but things came crashing down in 2016.
Early into the season, Colabello was suspended for 80 games after testing positive for a performance-enhancing substance. Was this the cause behind his breakout 2015 campaign? Possibly, although Colabello himself adamantly denies ever taking PEDs.
Speaking to Sportsnet, Colabello said: “I would never, have never and will never compromise the integrity of baseball. Ever. In my life. And whether that means taking a performance enhancing supplement—I just wouldn’t do it. I don’t do it. I haven’t done it. I won’t do it.”
On his return to action following his suspension, Colabello was sent to the minors and never recaptured his 2015 form, slashing .185/.254/.293 over 45 games between A+ Dunedin and AAA Buffalo. It was not a triumphant comeback to say the least, and did nothing to sway his critics.
The sceptic in me thinks Colabello won't match that 2015 output, not playing clean anyway. However, now he's been given another chance in Cleveland and by all accounts he comes across as a good locker-room guy and well-liked player. I'm hoping he can turn things around and if it's going to happen, it might as well be in Cleveland. The Indians have had some recent success resurrecting the careers of fading veterans, giving them the chance to shine one more time. Maybe Colabello can add his name to that list.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment